| Dr Timothy Brent Chafin, MD | |
|
500 Academy St S, Ahoskie, NC 27910-3248 | |
| (252) 209-3360 | |
| (252) 209-3687 |
| Full Name | Dr Timothy Brent Chafin |
|---|---|
| Gender | Male |
| Speciality | Interventional Pain Management |
| Experience | 24 Years |
| Location | 500 Academy St S, Ahoskie, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336167733 | NPI | - | NPPES |
| 89138AJ | Medicaid | NC | |
| 193427 | Other | MEDCOST | |
| 138AJ | Other | BCBSNC |
| Facility Name | Location | Facility Type |
|---|---|---|
| Vidant Roanoke Chowan Hospital | Ahoskie, NC | Hospital |
| Vidant Chowan Hospital | Edenton, NC | Hospital |
| Vidant Medical Center | Greenville, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Coastal Rehabilitation Inc | 9537071535 | 113 |
| East Carolina Health | 9739092727 | 8 |
News Archive
The U.S. Food and Drug Administration has approved the marketing of Ampyra™ (dalfampridine, formerly known as fampridine SR, from Acorda Therapeutics) for its ability to improve walking speed in people with any type of multiple sclerosis.
Chantix (varenicline) was shown to be effective with a favorable safety profile as an aid to smoking cessation treatment, according to three pivotal studies published in this week's Journal of the American Medical Association.
The research council FORMAS, Sweden, has granted 5.9 million SEK to a new research project that will study the environmental fate and effects of the anti-viral drug Tamiflu on the development on influenza resistance.
Researchers at Washington University School of Medicine in St. Louis have added a gene in the bacterium Salmonella to the short list of genes regulated by a new mechanism known as the riboswitch.
› Verified 9 days ago
| Entity Name | East Carolina Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093793473 PECOS PAC ID: 9739092727 Enrollment ID: O20031106000386 |
News Archive
The U.S. Food and Drug Administration has approved the marketing of Ampyra™ (dalfampridine, formerly known as fampridine SR, from Acorda Therapeutics) for its ability to improve walking speed in people with any type of multiple sclerosis.
Chantix (varenicline) was shown to be effective with a favorable safety profile as an aid to smoking cessation treatment, according to three pivotal studies published in this week's Journal of the American Medical Association.
The research council FORMAS, Sweden, has granted 5.9 million SEK to a new research project that will study the environmental fate and effects of the anti-viral drug Tamiflu on the development on influenza resistance.
Researchers at Washington University School of Medicine in St. Louis have added a gene in the bacterium Salmonella to the short list of genes regulated by a new mechanism known as the riboswitch.
› Verified 9 days ago
| Entity Name | Williamston Clinic Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811990443 PECOS PAC ID: 6709790082 Enrollment ID: O20031119000708 |
News Archive
The U.S. Food and Drug Administration has approved the marketing of Ampyra™ (dalfampridine, formerly known as fampridine SR, from Acorda Therapeutics) for its ability to improve walking speed in people with any type of multiple sclerosis.
Chantix (varenicline) was shown to be effective with a favorable safety profile as an aid to smoking cessation treatment, according to three pivotal studies published in this week's Journal of the American Medical Association.
The research council FORMAS, Sweden, has granted 5.9 million SEK to a new research project that will study the environmental fate and effects of the anti-viral drug Tamiflu on the development on influenza resistance.
Researchers at Washington University School of Medicine in St. Louis have added a gene in the bacterium Salmonella to the short list of genes regulated by a new mechanism known as the riboswitch.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Timothy Brent Chafin, MD Po Box 1385, Ahoskie, NC 27910-1385 Ph: (252) 209-3360 | Dr Timothy Brent Chafin, MD 500 Academy St S, Ahoskie, NC 27910-3248 Ph: (252) 209-3360 |
News Archive
The U.S. Food and Drug Administration has approved the marketing of Ampyra™ (dalfampridine, formerly known as fampridine SR, from Acorda Therapeutics) for its ability to improve walking speed in people with any type of multiple sclerosis.
Chantix (varenicline) was shown to be effective with a favorable safety profile as an aid to smoking cessation treatment, according to three pivotal studies published in this week's Journal of the American Medical Association.
The research council FORMAS, Sweden, has granted 5.9 million SEK to a new research project that will study the environmental fate and effects of the anti-viral drug Tamiflu on the development on influenza resistance.
Researchers at Washington University School of Medicine in St. Louis have added a gene in the bacterium Salmonella to the short list of genes regulated by a new mechanism known as the riboswitch.
› Verified 9 days ago